Skip to main content
Clinical Trials/ACTRN12617001541392
ACTRN12617001541392
Withdrawn
未知

Assessing the effectiveness of spinal cord stimulation versus spinal fusion surgery for the treatment of chronic low back pain: a prospective randomised study.

Monash Clinical Research0 sites58 target enrollmentNovember 7, 2017

Overview

Phase
未知
Intervention
Not specified
Conditions
Chronic Low Back Pain
Sponsor
Monash Clinical Research
Enrollment
58
Status
Withdrawn
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 7, 2017
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Monash Clinical Research

Eligibility Criteria

Inclusion Criteria

  • Have been diagnosed with chronic low back pain that has persisted for at least 90 days
  • Pain clinically suspected to be generated from single level lumbar disc disease as assessed by an investigator
  • Be 18 years of age or older
  • Have an average pain intensity of at least 6 out of 10 on the Numerical Pain Rating Scale at enrolment.
  • Willing and able to complete health questionnaires and pain scales as specified in the protocol
  • Willing and able to sign the study\-specific Patient Informed Consent form
  • Have private health insurance
  • No previous open back surgery
  • No previous SCS treatment
  • No RF treatment in past 12 months

Exclusion Criteria

  • Have plans to enroll in another clinical study during their participation in this study, or are currently enrolled in an interventional clinical study that could interfere in participation in the trial or affect the scientific soundness of this study
  • Have a medical condition or pain in other area(s), not intended to be treated with SCS or fusion, that could interfere with study procedures, accurate pain reporting, and/or confound evaluation of study endpoints, as determined by the Investigator (such as primary headache diagnosis and fibromyalgia).
  • Clinical back instability with surgically unstable spondylolisthesis as determined by the investigator
  • Have evidence of an active disruptive psychological or psychiatric disorder or other known condition significant enough to impact perception of pain, compliance of intervention and/or ability to evaluate treatment outcome, as determined by a psychologist or the physician
  • Have a current diagnosis of a progressive neurological disease such as multiple sclerosis, chronic inflammatory demyelinating polyneuropathy, rapidly progressive arachnoiditis, rapidly progressive diabetic peripheral neuropathy, brain or spinal cord tumor, and/or central deafferentation syndrome.
  • Have a current diagnosis of a coagulation disorder, bleeding diathesis that would put patient at any increased risk of bleeding during SCS or fusion procedure, progressive peripheral vascular disease or uncontrolled diabetes mellitus.
  • Having any clinical evidence of mechanical instability or progressive neurologic pathology that warrants surgical intervention.
  • Any previous history of surgery on the posterior elements (laminectomy, posterior fusion) that would disrupt/obliterate the posterior epidural space.
  • Have a condition currently requiring or likely to require the use of MRI or diathermy.
  • Have metastatic malignant disease or active local malignant disease.

Outcomes

Primary Outcomes

Not specified

Similar Trials